Global In Vitro Diagnostic (IVD) Products

In Vitro Diagnostic (IVD) Products Comprehensive Study by Type (Reagents & Kits, Instruments & Analyzers, Software & Services), Application (Infectious Diseases, Oncology (Cancer) Diagnostics, Cardiology, Endocrinology, Genetic Testing, Neurology, Autoimmune Diseases, Other), Technology (Immunoassays, Molecular Diagnostics, Hematology, Clinical Chemistry, Microbiology, Coagulation, Urinalysis, Other), End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Homecare & Self-Testing) Players and Region - Global Market Outlook to 2032

In Vitro Diagnostic (IVD) Products Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About In Vitro Diagnostic (IVD) Products
In Vitro Diagnostic (IVD) Products refer to medical devices, reagents, and instruments used to perform diagnostic tests on blood, urine, tissue, and other biological samples outside the human body. These tests help detect diseases, infections, genetic conditions, and overall health status, aiding in early diagnosis, treatment decisions, and disease monitoring. IVD products play a critical role in various medical fields, including infectious disease testing, oncology, cardiology, endocrinology, and genetic testing. The IVD market includes a wide range of technologies such as immunoassays, molecular diagnostics (PCR, NGS), clinical chemistry, hematology, and microbiology. These tests are commonly used in hospitals, diagnostic laboratories, academic research centers, and home-care settings. The demand for IVD products is driven by technological advancements, increasing prevalence of chronic and infectious diseases, growing aging populations, and the rise of personalized medicine. The COVID-19 pandemic significantly accelerated the adoption of IVD products, particularly molecular diagnostics and point-of-care testing. With the integration of AI, automation, and digital health solutions, the market continues to evolve, enhancing accuracy, efficiency, and accessibility. As healthcare shifts toward early detection and precision medicine, IVD products remain essential in transforming global healthcare outcomes.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global In Vitro Diagnostic (IVD) Products market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Roche Diagnostics (Switzerland), Abbott Laboratories (United States), Siemens Healthineers (Germany), Danaher Corporation (United States), Thermo Fisher Scientific (United States), Becton, Dickinson and Company (BD) (United States), Bio-Rad Laboratories (United States), bioMérieux (France), Qiagen (Germany) and Sysmex Corporation (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Hologic, Inc. (United States), Ortho Clinical Diagnostics (United States), Agilent Technologies (United States), Cepheid (subsidiary of Danaher) (United States) and QuidelOrtho Corporation (United States).

Segmentation Overview
AMA Research has segmented the market of Global In Vitro Diagnostic (IVD) Products market by Type (Reagents & Kits, Instruments & Analyzers and Software & Services), Application (Infectious Diseases, Oncology (Cancer) Diagnostics, Cardiology, Endocrinology, Genetic Testing, Neurology, Autoimmune Diseases and Other) and Region.



On the basis of geography, the market of In Vitro Diagnostic (IVD) Products has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the In Vitro Diagnostic (IVD) Products market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Expansion of point-of-care (POC) and rapid testing solutions.

Market Growth Drivers:
Rising prevalence of chronic and infectious diseases and Growing aging population leading to increased diagnostic needs.

Challenges:
Shortage of skilled professionals for complex testing procedures.

Restraints:
High costs of advanced diagnostic technologies.

Opportunities:
Integration of AI and digital health in diagnostics and Adoption of automation and robotics in laboratory testing.

Market Leaders and their expansionary development strategies
In Janaury 2025, European private-equity firm ArchiMed agreed to sell in vitro diagnostics company Diesse Diagnostica Senese to Fremman Capital for approximately €125 million. This transaction resulted in a 4.6 times return on ArchiMed's original investment, highlighting the value generated through strategic growth and innovation initiatives during their ownership



Key Target Audience
Manufacturers of Emergency Cricothyrotomy Kits, Suppliers of Emergency Cricothyrotomy Kits, Wholesalers, Distributors and Retailers of Emergency Cricothyrotomy Kits, Healthcare Industry, Governmental Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Reagents & Kits
  • Instruments & Analyzers
  • Software & Services
By Application
  • Infectious Diseases
  • Oncology (Cancer) Diagnostics
  • Cardiology
  • Endocrinology
  • Genetic Testing
  • Neurology
  • Autoimmune Diseases
  • Other
By Technology
  • Immunoassays
  • Molecular Diagnostics
  • Hematology
  • Clinical Chemistry
  • Microbiology
  • Coagulation
  • Urinalysis
  • Other

By End User
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Homecare & Self-Testing

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising prevalence of chronic and infectious diseases
      • 3.2.2. Growing aging population leading to increased diagnostic needs.
    • 3.3. Market Challenges
      • 3.3.1. Shortage of skilled professionals for complex testing procedures.
    • 3.4. Market Trends
      • 3.4.1. Expansion of point-of-care (POC) and rapid testing solutions.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global In Vitro Diagnostic (IVD) Products, by Type, Application, Technology, End User and Region (value) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global In Vitro Diagnostic (IVD) Products (Value)
      • 5.2.1. Global In Vitro Diagnostic (IVD) Products by: Type (Value)
        • 5.2.1.1. Reagents & Kits
        • 5.2.1.2. Instruments & Analyzers
        • 5.2.1.3. Software & Services
      • 5.2.2. Global In Vitro Diagnostic (IVD) Products by: Application (Value)
        • 5.2.2.1. Infectious Diseases
        • 5.2.2.2. Oncology (Cancer) Diagnostics
        • 5.2.2.3. Cardiology
        • 5.2.2.4. Endocrinology
        • 5.2.2.5. Genetic Testing
        • 5.2.2.6. Neurology
        • 5.2.2.7. Autoimmune Diseases
        • 5.2.2.8. Other
      • 5.2.3. Global In Vitro Diagnostic (IVD) Products by: Technology (Value)
        • 5.2.3.1. Immunoassays
        • 5.2.3.2. Molecular Diagnostics
        • 5.2.3.3. Hematology
        • 5.2.3.4. Clinical Chemistry
        • 5.2.3.5. Microbiology
        • 5.2.3.6. Coagulation
        • 5.2.3.7. Urinalysis
        • 5.2.3.8. Other
      • 5.2.4. Global In Vitro Diagnostic (IVD) Products by: End User (Value)
        • 5.2.4.1. Hospitals & Clinics
        • 5.2.4.2. Diagnostic Laboratories
        • 5.2.4.3. Academic & Research Institutes
        • 5.2.4.4. Homecare & Self-Testing
      • 5.2.5. Global In Vitro Diagnostic (IVD) Products Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. In Vitro Diagnostic (IVD) Products: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche Diagnostics (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Siemens Healthineers (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Danaher Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher Scientific (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Becton, Dickinson and Company (BD) (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bio-Rad Laboratories (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BioMérieux (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Qiagen (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sysmex Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global In Vitro Diagnostic (IVD) Products Sale, by Type, Application, Technology, End User and Region (value) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global In Vitro Diagnostic (IVD) Products (Value)
      • 7.2.1. Global In Vitro Diagnostic (IVD) Products by: Type (Value)
        • 7.2.1.1. Reagents & Kits
        • 7.2.1.2. Instruments & Analyzers
        • 7.2.1.3. Software & Services
      • 7.2.2. Global In Vitro Diagnostic (IVD) Products by: Application (Value)
        • 7.2.2.1. Infectious Diseases
        • 7.2.2.2. Oncology (Cancer) Diagnostics
        • 7.2.2.3. Cardiology
        • 7.2.2.4. Endocrinology
        • 7.2.2.5. Genetic Testing
        • 7.2.2.6. Neurology
        • 7.2.2.7. Autoimmune Diseases
        • 7.2.2.8. Other
      • 7.2.3. Global In Vitro Diagnostic (IVD) Products by: Technology (Value)
        • 7.2.3.1. Immunoassays
        • 7.2.3.2. Molecular Diagnostics
        • 7.2.3.3. Hematology
        • 7.2.3.4. Clinical Chemistry
        • 7.2.3.5. Microbiology
        • 7.2.3.6. Coagulation
        • 7.2.3.7. Urinalysis
        • 7.2.3.8. Other
      • 7.2.4. Global In Vitro Diagnostic (IVD) Products by: End User (Value)
        • 7.2.4.1. Hospitals & Clinics
        • 7.2.4.2. Diagnostic Laboratories
        • 7.2.4.3. Academic & Research Institutes
        • 7.2.4.4. Homecare & Self-Testing
      • 7.2.5. Global In Vitro Diagnostic (IVD) Products Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. In Vitro Diagnostic (IVD) Products: by Type(USD Million)
  • Table 2. In Vitro Diagnostic (IVD) Products Reagents & Kits , by Region USD Million (2019-2024)
  • Table 3. In Vitro Diagnostic (IVD) Products Instruments & Analyzers , by Region USD Million (2019-2024)
  • Table 4. In Vitro Diagnostic (IVD) Products Software & Services , by Region USD Million (2019-2024)
  • Table 5. In Vitro Diagnostic (IVD) Products: by Application(USD Million)
  • Table 6. In Vitro Diagnostic (IVD) Products Infectious Diseases , by Region USD Million (2019-2024)
  • Table 7. In Vitro Diagnostic (IVD) Products Oncology (Cancer) Diagnostics , by Region USD Million (2019-2024)
  • Table 8. In Vitro Diagnostic (IVD) Products Cardiology , by Region USD Million (2019-2024)
  • Table 9. In Vitro Diagnostic (IVD) Products Endocrinology , by Region USD Million (2019-2024)
  • Table 10. In Vitro Diagnostic (IVD) Products Genetic Testing , by Region USD Million (2019-2024)
  • Table 11. In Vitro Diagnostic (IVD) Products Neurology , by Region USD Million (2019-2024)
  • Table 12. In Vitro Diagnostic (IVD) Products Autoimmune Diseases , by Region USD Million (2019-2024)
  • Table 13. In Vitro Diagnostic (IVD) Products Other , by Region USD Million (2019-2024)
  • Table 14. In Vitro Diagnostic (IVD) Products: by Technology(USD Million)
  • Table 15. In Vitro Diagnostic (IVD) Products Immunoassays , by Region USD Million (2019-2024)
  • Table 16. In Vitro Diagnostic (IVD) Products Molecular Diagnostics , by Region USD Million (2019-2024)
  • Table 17. In Vitro Diagnostic (IVD) Products Hematology , by Region USD Million (2019-2024)
  • Table 18. In Vitro Diagnostic (IVD) Products Clinical Chemistry , by Region USD Million (2019-2024)
  • Table 19. In Vitro Diagnostic (IVD) Products Microbiology , by Region USD Million (2019-2024)
  • Table 20. In Vitro Diagnostic (IVD) Products Coagulation , by Region USD Million (2019-2024)
  • Table 21. In Vitro Diagnostic (IVD) Products Urinalysis , by Region USD Million (2019-2024)
  • Table 22. In Vitro Diagnostic (IVD) Products Other , by Region USD Million (2019-2024)
  • Table 23. In Vitro Diagnostic (IVD) Products: by End User(USD Million)
  • Table 24. In Vitro Diagnostic (IVD) Products Hospitals & Clinics , by Region USD Million (2019-2024)
  • Table 25. In Vitro Diagnostic (IVD) Products Diagnostic Laboratories , by Region USD Million (2019-2024)
  • Table 26. In Vitro Diagnostic (IVD) Products Academic & Research Institutes , by Region USD Million (2019-2024)
  • Table 27. In Vitro Diagnostic (IVD) Products Homecare & Self-Testing , by Region USD Million (2019-2024)
  • Table 28. South America In Vitro Diagnostic (IVD) Products, by Country USD Million (2019-2024)
  • Table 29. South America In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 30. South America In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 31. South America In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 32. South America In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 33. Brazil In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 34. Brazil In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 35. Brazil In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 36. Brazil In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 37. Argentina In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 38. Argentina In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 39. Argentina In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 40. Argentina In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 41. Rest of South America In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 42. Rest of South America In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 43. Rest of South America In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 44. Rest of South America In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 45. Asia Pacific In Vitro Diagnostic (IVD) Products, by Country USD Million (2019-2024)
  • Table 46. Asia Pacific In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 47. Asia Pacific In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 48. Asia Pacific In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 49. Asia Pacific In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 50. China In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 51. China In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 52. China In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 53. China In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 54. Japan In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 55. Japan In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 56. Japan In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 57. Japan In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 58. India In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 59. India In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 60. India In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 61. India In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 62. South Korea In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 63. South Korea In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 64. South Korea In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 65. South Korea In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 66. Taiwan In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 67. Taiwan In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 68. Taiwan In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 69. Taiwan In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 70. Australia In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 71. Australia In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 72. Australia In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 73. Australia In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 74. Rest of Asia-Pacific In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 75. Rest of Asia-Pacific In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 76. Rest of Asia-Pacific In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 77. Rest of Asia-Pacific In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 78. Europe In Vitro Diagnostic (IVD) Products, by Country USD Million (2019-2024)
  • Table 79. Europe In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 80. Europe In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 81. Europe In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 82. Europe In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 83. Germany In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 84. Germany In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 85. Germany In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 86. Germany In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 87. France In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 88. France In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 89. France In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 90. France In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 91. Italy In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 92. Italy In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 93. Italy In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 94. Italy In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 95. United Kingdom In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 96. United Kingdom In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 97. United Kingdom In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 98. United Kingdom In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 99. Netherlands In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 100. Netherlands In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 101. Netherlands In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 102. Netherlands In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 103. Rest of Europe In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 104. Rest of Europe In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 105. Rest of Europe In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 106. Rest of Europe In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 107. MEA In Vitro Diagnostic (IVD) Products, by Country USD Million (2019-2024)
  • Table 108. MEA In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 109. MEA In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 110. MEA In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 111. MEA In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 112. Middle East In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 113. Middle East In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 114. Middle East In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 115. Middle East In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 116. Africa In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 117. Africa In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 118. Africa In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 119. Africa In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 120. North America In Vitro Diagnostic (IVD) Products, by Country USD Million (2019-2024)
  • Table 121. North America In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 122. North America In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 123. North America In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 124. North America In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 125. United States In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 126. United States In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 127. United States In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 128. United States In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 129. Canada In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 130. Canada In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 131. Canada In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 132. Canada In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 133. Mexico In Vitro Diagnostic (IVD) Products, by Type USD Million (2019-2024)
  • Table 134. Mexico In Vitro Diagnostic (IVD) Products, by Application USD Million (2019-2024)
  • Table 135. Mexico In Vitro Diagnostic (IVD) Products, by Technology USD Million (2019-2024)
  • Table 136. Mexico In Vitro Diagnostic (IVD) Products, by End User USD Million (2019-2024)
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. In Vitro Diagnostic (IVD) Products: by Type(USD Million)
  • Table 148. In Vitro Diagnostic (IVD) Products Reagents & Kits , by Region USD Million (2027-2032)
  • Table 149. In Vitro Diagnostic (IVD) Products Instruments & Analyzers , by Region USD Million (2027-2032)
  • Table 150. In Vitro Diagnostic (IVD) Products Software & Services , by Region USD Million (2027-2032)
  • Table 151. In Vitro Diagnostic (IVD) Products: by Application(USD Million)
  • Table 152. In Vitro Diagnostic (IVD) Products Infectious Diseases , by Region USD Million (2027-2032)
  • Table 153. In Vitro Diagnostic (IVD) Products Oncology (Cancer) Diagnostics , by Region USD Million (2027-2032)
  • Table 154. In Vitro Diagnostic (IVD) Products Cardiology , by Region USD Million (2027-2032)
  • Table 155. In Vitro Diagnostic (IVD) Products Endocrinology , by Region USD Million (2027-2032)
  • Table 156. In Vitro Diagnostic (IVD) Products Genetic Testing , by Region USD Million (2027-2032)
  • Table 157. In Vitro Diagnostic (IVD) Products Neurology , by Region USD Million (2027-2032)
  • Table 158. In Vitro Diagnostic (IVD) Products Autoimmune Diseases , by Region USD Million (2027-2032)
  • Table 159. In Vitro Diagnostic (IVD) Products Other , by Region USD Million (2027-2032)
  • Table 160. In Vitro Diagnostic (IVD) Products: by Technology(USD Million)
  • Table 161. In Vitro Diagnostic (IVD) Products Immunoassays , by Region USD Million (2027-2032)
  • Table 162. In Vitro Diagnostic (IVD) Products Molecular Diagnostics , by Region USD Million (2027-2032)
  • Table 163. In Vitro Diagnostic (IVD) Products Hematology , by Region USD Million (2027-2032)
  • Table 164. In Vitro Diagnostic (IVD) Products Clinical Chemistry , by Region USD Million (2027-2032)
  • Table 165. In Vitro Diagnostic (IVD) Products Microbiology , by Region USD Million (2027-2032)
  • Table 166. In Vitro Diagnostic (IVD) Products Coagulation , by Region USD Million (2027-2032)
  • Table 167. In Vitro Diagnostic (IVD) Products Urinalysis , by Region USD Million (2027-2032)
  • Table 168. In Vitro Diagnostic (IVD) Products Other , by Region USD Million (2027-2032)
  • Table 169. In Vitro Diagnostic (IVD) Products: by End User(USD Million)
  • Table 170. In Vitro Diagnostic (IVD) Products Hospitals & Clinics , by Region USD Million (2027-2032)
  • Table 171. In Vitro Diagnostic (IVD) Products Diagnostic Laboratories , by Region USD Million (2027-2032)
  • Table 172. In Vitro Diagnostic (IVD) Products Academic & Research Institutes , by Region USD Million (2027-2032)
  • Table 173. In Vitro Diagnostic (IVD) Products Homecare & Self-Testing , by Region USD Million (2027-2032)
  • Table 174. South America In Vitro Diagnostic (IVD) Products, by Country USD Million (2027-2032)
  • Table 175. South America In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 176. South America In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 177. South America In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 178. South America In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 179. Brazil In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 180. Brazil In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 181. Brazil In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 182. Brazil In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 183. Argentina In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 184. Argentina In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 185. Argentina In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 186. Argentina In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 187. Rest of South America In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 188. Rest of South America In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 189. Rest of South America In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 190. Rest of South America In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 191. Asia Pacific In Vitro Diagnostic (IVD) Products, by Country USD Million (2027-2032)
  • Table 192. Asia Pacific In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 193. Asia Pacific In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 194. Asia Pacific In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 195. Asia Pacific In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 196. China In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 197. China In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 198. China In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 199. China In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 200. Japan In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 201. Japan In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 202. Japan In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 203. Japan In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 204. India In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 205. India In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 206. India In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 207. India In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 208. South Korea In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 209. South Korea In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 210. South Korea In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 211. South Korea In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 212. Taiwan In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 213. Taiwan In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 214. Taiwan In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 215. Taiwan In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 216. Australia In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 217. Australia In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 218. Australia In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 219. Australia In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 220. Rest of Asia-Pacific In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 221. Rest of Asia-Pacific In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 222. Rest of Asia-Pacific In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 223. Rest of Asia-Pacific In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 224. Europe In Vitro Diagnostic (IVD) Products, by Country USD Million (2027-2032)
  • Table 225. Europe In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 226. Europe In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 227. Europe In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 228. Europe In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 229. Germany In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 230. Germany In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 231. Germany In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 232. Germany In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 233. France In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 234. France In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 235. France In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 236. France In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 237. Italy In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 238. Italy In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 239. Italy In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 240. Italy In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 241. United Kingdom In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 242. United Kingdom In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 243. United Kingdom In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 244. United Kingdom In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 245. Netherlands In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 246. Netherlands In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 247. Netherlands In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 248. Netherlands In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 249. Rest of Europe In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 250. Rest of Europe In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 251. Rest of Europe In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 252. Rest of Europe In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 253. MEA In Vitro Diagnostic (IVD) Products, by Country USD Million (2027-2032)
  • Table 254. MEA In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 255. MEA In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 256. MEA In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 257. MEA In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 258. Middle East In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 259. Middle East In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 260. Middle East In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 261. Middle East In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 262. Africa In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 263. Africa In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 264. Africa In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 265. Africa In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 266. North America In Vitro Diagnostic (IVD) Products, by Country USD Million (2027-2032)
  • Table 267. North America In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 268. North America In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 269. North America In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 270. North America In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 271. United States In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 272. United States In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 273. United States In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 274. United States In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 275. Canada In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 276. Canada In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 277. Canada In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 278. Canada In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 279. Mexico In Vitro Diagnostic (IVD) Products, by Type USD Million (2027-2032)
  • Table 280. Mexico In Vitro Diagnostic (IVD) Products, by Application USD Million (2027-2032)
  • Table 281. Mexico In Vitro Diagnostic (IVD) Products, by Technology USD Million (2027-2032)
  • Table 282. Mexico In Vitro Diagnostic (IVD) Products, by End User USD Million (2027-2032)
  • Table 283. Research Programs/Design for This Report
  • Table 284. Key Data Information from Secondary Sources
  • Table 285. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global In Vitro Diagnostic (IVD) Products: by Type USD Million (2019-2024)
  • Figure 5. Global In Vitro Diagnostic (IVD) Products: by Application USD Million (2019-2024)
  • Figure 6. Global In Vitro Diagnostic (IVD) Products: by Technology USD Million (2019-2024)
  • Figure 7. Global In Vitro Diagnostic (IVD) Products: by End User USD Million (2019-2024)
  • Figure 8. South America In Vitro Diagnostic (IVD) Products Share (%), by Country
  • Figure 9. Asia Pacific In Vitro Diagnostic (IVD) Products Share (%), by Country
  • Figure 10. Europe In Vitro Diagnostic (IVD) Products Share (%), by Country
  • Figure 11. MEA In Vitro Diagnostic (IVD) Products Share (%), by Country
  • Figure 12. North America In Vitro Diagnostic (IVD) Products Share (%), by Country
  • Figure 13. Global In Vitro Diagnostic (IVD) Products share by Players 2024 (%)
  • Figure 14. Global In Vitro Diagnostic (IVD) Products share by Players (Top 3) 2024(%)
  • Figure 15. Global In Vitro Diagnostic (IVD) Products share by Players (Top 5) 2024(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Roche Diagnostics (Switzerland) Revenue: by Geography 2024
  • Figure 19. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 20. Abbott Laboratories (United States) Revenue: by Geography 2024
  • Figure 21. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Siemens Healthineers (Germany) Revenue: by Geography 2024
  • Figure 23. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Danaher Corporation (United States) Revenue: by Geography 2024
  • Figure 25. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 26. Thermo Fisher Scientific (United States) Revenue: by Geography 2024
  • Figure 27. Becton, Dickinson and Company (BD) (United States) Revenue, Net Income and Gross profit
  • Figure 28. Becton, Dickinson and Company (BD) (United States) Revenue: by Geography 2024
  • Figure 29. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Bio-Rad Laboratories (United States) Revenue: by Geography 2024
  • Figure 31. BioMérieux (France) Revenue, Net Income and Gross profit
  • Figure 32. BioMérieux (France) Revenue: by Geography 2024
  • Figure 33. Qiagen (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Qiagen (Germany) Revenue: by Geography 2024
  • Figure 35. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Sysmex Corporation (Japan) Revenue: by Geography 2024
  • Figure 37. Global In Vitro Diagnostic (IVD) Products: by Type USD Million (2027-2032)
  • Figure 38. Global In Vitro Diagnostic (IVD) Products: by Application USD Million (2027-2032)
  • Figure 39. Global In Vitro Diagnostic (IVD) Products: by Technology USD Million (2027-2032)
  • Figure 40. Global In Vitro Diagnostic (IVD) Products: by End User USD Million (2027-2032)
  • Figure 41. South America In Vitro Diagnostic (IVD) Products Share (%), by Country
  • Figure 42. Asia Pacific In Vitro Diagnostic (IVD) Products Share (%), by Country
  • Figure 43. Europe In Vitro Diagnostic (IVD) Products Share (%), by Country
  • Figure 44. MEA In Vitro Diagnostic (IVD) Products Share (%), by Country
  • Figure 45. North America In Vitro Diagnostic (IVD) Products Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Roche Diagnostics (Switzerland)
  • Abbott Laboratories (United States)
  • Siemens Healthineers (Germany)
  • Danaher Corporation (United States)
  • Thermo Fisher Scientific (United States)
  • Becton, Dickinson and Company (BD) (United States)
  • Bio-Rad Laboratories (United States)
  • bioMérieux (France)
  • Qiagen (Germany)
  • Sysmex Corporation (Japan)
Additional players considered in the study are as follows:
Hologic, Inc. (United States) , Ortho Clinical Diagnostics (United States) , Agilent Technologies (United States) , Cepheid (subsidiary of Danaher) (United States) , QuidelOrtho Corporation (United States)
Select User Access Type

Key Highlights of Report


Feb 2025 243 Pages 72 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global In Vitro Diagnostic (IVD) Products Quantitative research analysis
Global In Vitro Diagnostic (IVD) Products Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Roche Diagnostics (Switzerland), Abbott Laboratories (United States), Siemens Healthineers (Germany), Danaher Corporation (United States), Thermo Fisher Scientific (United States), Becton, Dickinson and Company (BD) (United States), Bio-Rad Laboratories (United States), bioMérieux (France), Qiagen (Germany) and Sysmex Corporation (Japan) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Expansion of point-of-care (POC) and rapid testing solutions." is seen as one of major influencing trends for In Vitro Diagnostic (IVD) Products Market during projected period 2024-2032.
The In Vitro Diagnostic (IVD) Products market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global In Vitro Diagnostic (IVD) Products Report?

Have a Query? Click Here

Other Related Reports

Veterinary X-ray Comprehensive Study by Type (Digital X-ray, Analog X-ray  ), Application (Orthopedics and Trauma, Oncology, Dental Applications), Technology (Direct (Capture) Radiography Systems, Co...
$ 3750
Growth Medium Comprehensive Study by Type (Classical Media, Stem Cell Media, Lysogeny Broth, Chemically Defined Media, Specialty Media, Serum-free Media, Others), Application (Cancer Research, Biopha...
$ 3750
Skin Biopsy Comprehensive Study by Disease Type (Skin Cancer, Actinic Keratosis, Dermatitis, Psoriasis, Fungal Infections, Eczema, Others), Techniques (Shave Biopsy, Punch Biopsy, Wedge Biopsy, Sauce...
$ 3800
Chemotherapy Induced Anemia Comprehensive Study by Drug Type (Androxy Oral, Epoetin Alfa Injection, Epogen Injection, Procrit Injection, Aranesp injection, Others), Type of Anemia (Mild Anemia, Moder...
$ 3750
Pillow Support Systems Comprehensive Study by Type (Neck Pillow, Spinal Support Pillow, Leg Raiser, Knee Support Pillow, V Pillow, Travel Pillow, Others), Application (Image Diagnosis, Surgery, Perso...
$ 3650
Beta Thalassemia Testing Comprehensive Study by Application (Hospitals, Biotechnological Laboratories, Diagnostic Laboratories, Educational Research Institutes, Pharmaceutical Industries), Technology...
$ 2500